Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate

by NASDAQ Market News June 10, 2021

NASDAQ Market News
Click here to email author

Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations

Monthly information on share capital and company voting rights

Ads